SRP-9004
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SRP-9004, covering 2022-04-01 to 2025-09-04. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Efficacy of SRP-9004 Administered by Systemic Infusion in Limb Girdle Muscular Dystrophy Type 2D/R3 Participants in the United States [Phase 1]